Christopher Downs, Chief Financial Officer at CNS Pharmaceuticals, Inc. (CNSP), bought 27,000 shares at $1.27 ($34K) on 2023-08-22, disclosed to the SEC on 2023-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNSP | BUY | 2021-12-07 | $5K | — | Filing → |
| CNSP | BUY | 2021-11-22 | $5K | — | Filing → |
| CNSP | BUY | 2020-08-25 | $290K | — | Filing → |